220 related articles for article (PubMed ID: 22811512)
1. Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
Okonta KE; Edwin F; Falase B
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):690-4. PubMed ID: 22811512
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
[TBL] [Abstract][Full Text] [Related]
3. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
[TBL] [Abstract][Full Text] [Related]
4. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
[TBL] [Abstract][Full Text] [Related]
5. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N
Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
[TBL] [Abstract][Full Text] [Related]
6. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
[TBL] [Abstract][Full Text] [Related]
7. Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children.
Herbertson M; Kenet G
Haemophilia; 2008 Jul; 14(4):753-62. PubMed ID: 18445016
[TBL] [Abstract][Full Text] [Related]
8. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
Chapman AJ; Blount AL; Davis AT; Hooker RL
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
[TBL] [Abstract][Full Text] [Related]
10. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.
Veldman A; Neuhaeuser C; Akintuerk H; Thul J; Gehron J; Schranz D; Michel-Behnke I
Paediatr Anaesth; 2007 Dec; 17(12):1176-81. PubMed ID: 17986036
[TBL] [Abstract][Full Text] [Related]
11. Recombinant-activated factor VII in the paediatric cardiac surgery: single unit experience.
Agarwal V; Okonta KE; Lal PS
Afr J Paediatr Surg; 2012; 9(3):193-7. PubMed ID: 23250238
[TBL] [Abstract][Full Text] [Related]
12. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
[TBL] [Abstract][Full Text] [Related]
13. Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: an observational study of practices in 23 French cardiac centres (2005-7).
Hacquard M; Durand M; Lecompte T; Boini S; Briançon S; Carteaux JP
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1320-7. PubMed ID: 21550261
[TBL] [Abstract][Full Text] [Related]
14. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
[TBL] [Abstract][Full Text] [Related]
15. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis.
Tritapepe L; De Santis V; Vitale D; Nencini C; Pellegrini F; Landoni G; Toscano F; Miraldi F; Pietropaoli P
Crit Care Med; 2007 Jul; 35(7):1685-90. PubMed ID: 17522585
[TBL] [Abstract][Full Text] [Related]
16. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
Hoffmann T; Assmann A; Dierksen A; Roussel E; Ullrich S; Lichtenberg A; Albert A; Sixt S
J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
[TBL] [Abstract][Full Text] [Related]
17. eComment. Recombinant activated factor VII in pediatric cardiac surgery: possibilities and limitations.
Bockeria LA; Kupryashov AA; Samsonova NN
Interact Cardiovasc Thorac Surg; 2012 Oct; 15(4):694-5. PubMed ID: 22991396
[No Abstract] [Full Text] [Related]
18. The utility of thromboelastography for guiding recombinant activated factor VII therapy for refractory hemorrhage after cardiac surgery.
Wasowicz M; Meineri M; McCluskey SM; Mitsakakis N; Karkouti K
J Cardiothorac Vasc Anesth; 2009 Dec; 23(6):828-34. PubMed ID: 19467888
[TBL] [Abstract][Full Text] [Related]
19. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery].
Gong ZY; Gao CQ; Xiao CS; Li BJ; Ma XH; Zhang CM
Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1497-501. PubMed ID: 19094631
[TBL] [Abstract][Full Text] [Related]
20. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage.
Feih JT; Juul JJ; G Rinka JR; Baumann Kreuziger LM; Pagel PS; Tawil JN
Ann Card Anaesth; 2019; 22(4):388-393. PubMed ID: 31621674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
